NEWS
Industry Cooperation
- Publish Date：2024-11-13
Advancing a New Era in Smart Healthcare: NYCU Partners with Shin Kong Hospital and PHISON Electronics to Drive Medical Innovation with GenAI
Translated by Chance Lai
______
______
The wave of Generative AI (GenAI) is now reaching the healthcare industry! On November 12, National Yang Ming Chiao Tung University (NYCU), Shin Kong Hospital, and PHISON Electronics announced a groundbreaking collaboration to advance medical innovation through GenAI. This partnership aims to strengthen academic and medical research, elevating diagnostic accuracy through a fusion of expertise across healthcare, academia, and technology.
GenAI Powers Medical Innovation: Enhancing Diagnostic Efficiency and Advancing Data Analysis
The collaboration is designed to leverage the unique strengths of all three partners to promote the use of GenAI in healthcare. Focusing on enhancing diagnostic efficiency, improving patient care, and accelerating health data analysis, the initiative seeks to pioneer new horizons in smart healthcare. The first phase of this project will involve PET image analysis and the generation of case reports, targeting applications in low-dose CT scans for lung cancer and pelvic tumor analysis.
Yu-De Wu, NYCU's Vice President of Research and Development, explained that traditionally, physicians manually analyze PET images and often struggle with ambiguous boundaries in lymph node abnormalities. Using patient images from Shin Kong Hospital to train the AI, the team developed a system that accurately identifies lymph node lesions in the pelvic region. Combined with Phison's Generative AI, the technology generates comprehensive case reports that apply to PET and LDCT scans. These advancements are expected to receive medical device certification from Taiwan's Ministry of Health and Welfare by October next year, paving the way for clinical implementation at Shin Kong Hospital.
PHISON Electronics CEO Khein-Seng Pua noted that GenAI represents the latest evolution, offering readily digestible information instead of requiring users to search and synthesize information. This technology can accelerate employee training, streamline onboarding, and enhance workforce quality and efficiency.
GenAI Powers Medical Innovation: Enhancing Diagnostic Efficiency and Advancing Data Analysis
The collaboration is designed to leverage the unique strengths of all three partners to promote the use of GenAI in healthcare. Focusing on enhancing diagnostic efficiency, improving patient care, and accelerating health data analysis, the initiative seeks to pioneer new horizons in smart healthcare. The first phase of this project will involve PET image analysis and the generation of case reports, targeting applications in low-dose CT scans for lung cancer and pelvic tumor analysis.
Yu-De Wu, NYCU's Vice President of Research and Development, explained that traditionally, physicians manually analyze PET images and often struggle with ambiguous boundaries in lymph node abnormalities. Using patient images from Shin Kong Hospital to train the AI, the team developed a system that accurately identifies lymph node lesions in the pelvic region. Combined with Phison's Generative AI, the technology generates comprehensive case reports that apply to PET and LDCT scans. These advancements are expected to receive medical device certification from Taiwan's Ministry of Health and Welfare by October next year, paving the way for clinical implementation at Shin Kong Hospital.
PHISON Electronics CEO Khein-Seng Pua noted that GenAI represents the latest evolution, offering readily digestible information instead of requiring users to search and synthesize information. This technology can accelerate employee training, streamline onboarding, and enhance workforce quality and efficiency.
Concerns Around AI in Medicine: Security and the Role of Physicians
Shin Kong Hospital Chairman Eugene Wu addressed concerns over data security, highlighting the potential risks if patient data falls into the hands of private insurers. Misuse of medical data could lead to denied coverage based on hereditary concerns, posing significant financial and emotional challenges for patients. Wu emphasized, “Data management in healthcare AI must be even stricter than in finance.”
Shin Kong Hospital Vice President Tzu-Jen Hung added that, while AI can generate clinical reports, physicians must still review and approve them before becoming official records. “In the future,” he stated, “those who understand AI will replace those who don’t.”
NYCU President Chi-Hung Lin commented that in just over three years since the merger of Yang Ming and Chiao Tung universities, the institution has experienced rapid growth across various fields. He highlighted the transformative potential of GenAI in numerous industries, expressing hope that this collaboration will further advance research, teaching, and patient care.
Through this partnership, we aim to redefine healthcare boundaries, using creativity and collaboration to contribute to the well-being of humanity.
The MOU was signed by NYCU President Chi-Hung Lin (left), Shin Kong Hospital Superintendent Sheng-Mou Hou (center), and PHISON Electronics CEO Khein-Seng Pua (right).
Related Image(s)：
